| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G |
| 16 Nov 2026 | SCHEDULE 13G |
| 16 Nov 2026 | SCHEDULE 13G |
| 16 Nov 2026 | SCHEDULE 13G/A |
| 10 Nov 2026 | SCHEDULE 13G |
| 09 Nov 2026 | S-8 |
| 05 Nov 2026 | 10-Q |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition
Completed merger with Cyclerion Therapeutics and concurrent $380 million private placement |
| 22 Oct 2026 | 144 |
| 15 Oct 2026 | SCHEDULE 13G/A |
| 15 Oct 2026 | DEF 14A |
| 07 Oct 2026 | SCHEDULE 13G/A |
| 05 Oct 2026 | PRE 14A |
| 23 Sep 2026 | 144 |
| 22 Sep 2026 | 144 |
| 18 Sep 2026 | SCHEDULE 13G |
| 18 Sep 2026 | 144 |
| 16 Sep 2026 | SCHEDULE 13G |
| 15 Sep 2026 | SCHEDULE 13D |
| 11 Sep 2026 | SCHEDULE 13D |
Loading...